Nexalin Technology, Inc. Increase (Decrease) in Accrued Liabilities
Nexalin Technology, Inc. (NXL) reported Increase (Decrease) in Accrued Liabilities of $215.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-12
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $218.24K.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$2.49K, a 195.84% decline year-over-year.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $318.72K, a 23.58% increase year-over-year.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$35.97K, a 556.45% decline year-over-year.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $252.01K, a 94.66% increase from fiscal 2024.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $129.46K.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$163.54K, a 265.01% decline from fiscal 2022.
- Nexalin Technology, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $99.11K, a 0.31% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $215.75K 10-Q · filed 2026-08-12 | $534.47K derived: sum of 3 quarters · filed 2026-08-12 | $498.50K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$2.49K 10-Q · filed 2026-05-08 | $316.23K derived: sum of 2 quarters · filed 2026-05-08 | $280.26K derived: sum of 3 quarters · filed 2026-05-08 | $246.92K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $318.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $282.75K derived: sum of 2 quarters · filed 2026-03-25 | $249.41K derived: sum of 3 quarters · filed 2026-08-12 | $252.01K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | -$35.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$69.31K derived: sum of 2 quarters · filed 2026-08-12 | -$66.71K 10-Q · filed 2025-11-14 | $191.18K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$33.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$30.74K 10-Q · filed 2026-08-12 | -$18.74K 10-Q · filed 2025-08-06 | $227.16K derived: sum of 3 quarters · filed 2026-08-12 | $235.04K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $2.60K 10-Q · filed 2026-05-08 | $260.50K derived: sum of 2 quarters · filed 2026-05-08 | $268.38K derived: sum of 3 quarters · filed 2026-05-08 | $37.63K derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $257.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $265.78K derived: sum of 2 quarters · filed 2026-03-25 | $35.03K derived: sum of 3 quarters · filed 2026-03-25 | $129.46K 10-K · filed 2026-03-25 | -$110.54K 10-K · filed 2025-03-14 | |
| 2024-09-30 | $7.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$222.87K derived: sum of 2 quarters · filed 2025-11-14 | -$128.44K 10-Q · filed 2025-11-14 | -$359.04K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$230.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$136.32K 10-Q · filed 2025-08-06 | -$366.93K derived: sum of 3 quarters · filed 2025-09-23 | -$363.67K derived: sum of 4 quarters · filed 2025-09-23 | ||
| 2024-03-31 | $94.43K 10-Q · filed 2025-05-13 | -$136.18K derived: sum of 2 quarters · filed 2025-09-23 | -$132.92K derived: sum of 3 quarters · filed 2025-09-23 | -$126.95K derived: sum of 4 quarters · filed 2025-09-23 | ||
| 2023-12-31 | -$230.61K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | -$227.35K derived: sum of 2 quarters · filed 2025-09-23 | -$221.38K derived: sum of 3 quarters · filed 2025-09-23 | -$163.54K 10-K/A · filed 2025-09-23 | ||
| 2023-09-30 | $3.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $9.23K derived: sum of 2 quarters · filed 2024-11-08 | $67.07K 10-Q · filed 2024-11-08 | $164.39K derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $5.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $63.81K 10-Q · filed 2024-08-08 | $161.13K derived: sum of 3 quarters · filed 2024-08-08 | $174.97K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $57.84K 10-Q · filed 2024-05-10 | $155.16K derived: sum of 2 quarters · filed 2024-05-10 | $169.00K derived: sum of 3 quarters · filed 2024-05-10 | $183.62K derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $97.32K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $111.16K derived: sum of 2 quarters · filed 2024-03-27 | $125.78K derived: sum of 3 quarters · filed 2024-03-27 | $99.11K 10-K · filed 2024-03-27 | ||
| 2022-09-30 | $13.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $28.46K derived: sum of 2 quarters · filed 2023-11-13 | $1.78K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $14.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$12.05K 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$26.68K 10-Q · filed 2023-05-10 | |||||
| 2021-12-31 | $99.41K 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |